Potential of L-BUTHIONINE (cas 13073-21-7) sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer☆

Add time:10/01/2019    Source:sciencedirect.com

L-BUTHIONINE (cas 13073-21-7) sulfoximine (BSO) is a potent inhibitor of glutathione biosynthesis and studies have shown that it is capable of enhancing the apoptotic effects of several chemotherapeutic agents. Previous studies have shown that long-term antihormonal therapy leads to acquired drug resistance and that estrogen, which is normally a survival signal, is a potent apoptotic agent in these resistant cells. Interestingly, we have developed an antihormone-resistant breast cancer cell line, MCF-7:2A, which is resistant to estrogen-induced apoptosis but has elevated levels of glutathione. In the present study, we examined whether BSO is capable of sensitizing antihormone-resistant MCF-7:2A cells to estrogen-induced apoptosis. Our results showed that treatment of MCF-7:2A cells with 1 nM E2 plus 100 μM BSO combination for 1 week reduced the growth of these cells by almost 80–90% whereas the individual treatments had no significant effect on growth. TUNEL and 4′,6-diamidino-2-phenylindole (DAPI) staining showed that the inhibitory effect of the combination treatment was due to apoptosis. Our data indicates that glutathione participates in retarding apoptosis in antihormone-resistant human breast cancer cells and that depletion of this molecule by BSO may be critical in predisposing resistant cells to estrogen-induced apoptosis.

We also recommend Trading Suppliers and Manufacturers of L-BUTHIONINE (cas 13073-21-7). Pls Click Website Link as below: cas 13073-21-7 suppliers

Prev:Research reportSensory-motor performance after acute glutathione depletion by L-BUTHIONINE (cas 13073-21-7) sulfoximine injection into substantia nigra pars compacta
Next:Original ContributionMechanisms of BSO (L-BUTHIONINE (cas 13073-21-7)-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma)